Literature DB >> 3177671

Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarction.

R G Gay1, S Graham, M Aguirre, S Goldman, E Morkin.   

Abstract

The effects of treatment with L-thyroxine (T4) for 10-12 days on left ventricular (LV) function and myosin isoenzyme content in rats with LV dysfunction after myocardial infarction were studied. Electrocardiogram (ECG) criteria were used to select animals with large myocardial infarctions. These animals were divided into six groups: control and five treatment groups that received daily subcutaneous injections of T4 (1.5, 3, 6, 10, or 15 micrograms/100 g body wt) for 10-12 days. Intravascular pressures were then measured with micromanometer-tipped catheters, and the hearts were analyzed for myosin isoenzyme distribution. The lowest dose of T4 (1.5 micrograms) produced no changes in heart rate, LV pressure or aortic pressure (AoP), myosin isoenzyme composition, or serum T4 levels. Larger doses of T4 (3, 6, 10, and 15 micrograms) produced increases in LV rate of pressure development (dP/dt), heart rate, and T4 levels but did not change LV pressure or AoP. Myosin isoenzyme composition in the control group showed increases in the proportion of the V3 form and decreases in the V1 form compared with the normal pattern. T4 administration produced dose-dependent increases in the V1 myosin isoform and corresponding decreases in the amount of the V2 and V3 forms. Heart rate increases observed with larger doses of T4 could be prevented by addition of propranolol (500 mg/l) to the drinking water. However, in rats treated with T4 and propranolol, LV pressure, AoP, LV dP/dt, and myosin isoenzyme composition were unchanged compared with T4-treated rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177671     DOI: 10.1152/ajpheart.1988.255.4.H801

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts.

Authors:  K C Chang; V M Figueredo; J H Schreur; K Kariya; M W Weiner; P C Simpson; S A Camacho
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Effect of triiodothyronine administration in experimental myocardial injury.

Authors:  R B Hsu; T S Huang; Y S Chen; S H Chu
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

Review 3.  Rebuilding the post-infarcted myocardium by activating 'physiologic' hypertrophic signaling pathways: the thyroid hormone paradigm.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2008-09-05       Impact factor: 4.214

4.  Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure.

Authors:  R L Duerr; S Huang; H R Miraliakbar; R Clark; K R Chien; J Ross
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

5.  Thyroid (dys)function in heart failure: is it a potential target for medical treatment?

Authors:  Alessandro Pingitore; Giorgio Iervasi
Journal:  Vasc Health Risk Manag       Date:  2005

6.  Selective thyroid hormone receptor modulators.

Authors:  Girish Raparti; Suyog Jain; Karuna Ramteke; Mangala Murthy; Ravi Ghanghas; Sunita Ramanand; Jaiprakash Ramanand
Journal:  Indian J Endocrinol Metab       Date:  2013-03

7.  Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats.

Authors:  Yue-Feng Chen; Nathan Y Weltman; Xiang Li; Steven Youmans; David Krause; Anthony Martin Gerdes
Journal:  J Transl Med       Date:  2013-02-14       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.